Endoscopic Retrograde Cholangiopancreatography/ERCP Market by Product, Procedure, End User - Global Forecast to 2026

Endoscopic Retrograde Cholangiopancreatography/ERCP Market by Product, Procedure, End User - Global Forecast to 2026

  • March 2022 •
  • 231 pages •
  • Report ID: 6247603 •
  • Format: PDF
The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2.0 billion by 2026 from USD 1.3 billion in 2021, at a CAGR of 9.6% during the forecast period. The growth of this market is majorly attributed to factors such as the rising incidence of cancer, increasing investments by governments and healthcare organizations to improve endoscopy research, growing focus on investments by hospitals for advanced endoscopy instruments, and the increasing preference for minimally invasive surgeries. On the other hand, the high costs of endoscopic retrograde cholangiopancreatography devices, the development of other procedures like EUS and MRCP, and the shortage of trained physicians and endoscopists are factors expected to restrain the market growth to a certain extent.

The endotherapy devices segment accounted for the largest share of the endoscopic retrograde cholangiopancreatography market in 2020.
Based on products, the endoscopic retrograde cholangiopancreatography market has been segmented into endoscopes, endotherapy devices, visualization systems, energy devices, and others. The factors attributing to the large revenue of the endotherapy devices segment include the growing preference for minimally invasive surgeries and the increasing prevalence of gastrointestinal conditions.

The markets in Asia Pacific and Latin America is projected to witness the highest growth rate during the forecast period (2021–2026).
North America accounted for the largest share of the Endoscopic retrograde cholangiopancreatography market in 2020. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type (Supply-side): Tier 1: 55%, Tier 2: 25%, and Tier 3: 20%
• By Designation: C-level: 43%, Director-level: 32%, and Others: 25%
• By Region: North America: 38%, Europe: 23%, Asia-Pacific: 29%, Latin America: 5%, and Middle East & Africa: 5%
The major players in the global endoscopic retrograde cholangiopancreatography market include Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co.KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), and B.

Braun Melsungen AG (Germany).
Other players in the market include Hobbs Medical, Inc. (US), STERIS PLC (US), Merit Medical Systems, Inc. (US), TeleMed Systems, Inc. (US), Changzhou Health Microport Medical Device Co., LTD. (China), Medi-Globe GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), Huger Medical Instrument Co., Ltd. (China), IntroMedic Co., Ltd. (Republic of Korea), SonoScape Medical Corporation (China), Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. (China), Ottomed (India), Kimberly-Clark Corporation (US), and Shaili Endoscopy (India).

Research Coverage:
The report analyzes the endoscopic retrograde cholangiopancreatography market and aims at estimating the market size and future growth potential of this market based on various segments such as product, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the endoscopic retrograde cholangiopancreatography market. The report analyzes the market based on the products and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the endoscopic retrograde cholangiopancreatography market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of endoscopic retrograde cholangiopancreatography solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the endoscopic retrograde cholangiopancreatography market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the endoscopic retrograde cholangiopancreatography markets.
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.